Publications by authors named "Ingmar Hoerr"

Claim this Profile
H
Historic nucleic acids isolated by Friedrich Miescher contain RNA besides DNA.
Andreas Thess, Ingmar Hoerr, Benyamin Yazdan Panah, Günther Jung, Ralf Dahm

Biol Chem· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Martin Sebastian, Andreas Schröder, Birgit Scheel, Henoch S Hong, Anke Muth, Ingmar Hoerr

Cancer Immunol Immunother· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A successful founder off the beaten path.
Ingmar Hoerr

Nat Biotechnol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial.
Martin Alberer, Ulrike Gnad-Vogt, Henoch Sangjoon Hong, Keyvan Tadjalli Mehr, Linus Backert, Ingmar Hoerr

Lancet· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.
Henoch S Hong, Sven D Koch, Birgit Scheel, Ulrike Gnad-Vogt, Andreas Schröder, Ingmar Hoerr

Oncoimmunology· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy.
Susanne M Rittig, Maik Haentschel, Katrin J Weimer, Annkristin Heine, Martin R Müller, Ingmar Hoerr

Oncoimmunology· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.
Hubert Kübler, Birgit Scheel, Ulrike Gnad-Vogt, Kurt Miller, Wolfgang Schultze-Seemann, Ingmar Hoerr

J Immunother Cancer· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.
Susanne M Rittig, Maik Haentschel, Katrin J Weimer, Annkristin Heine, Martin R Muller, Ingmar Hoerr

Mol Ther· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients.
Benjamin Weide, Steve Pascolo, Birgit Scheel, Evelyna Derhovanessian, Annette Pflugfelder, Ingmar Hoerr

J Immunother· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA.
Benjamin Weide, Jean-Philippe Carralot, Anne Reese, Birgit Scheel, Thomas Kurt Eigentler, Ingmar Hoerr

J Immunother· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.
Birgit Scheel, Steffen Aulwurm, Jochen Probst, Lothar Stitz, Ingmar Hoerr

Eur J Immunol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the ribonuclease activity on the skin surface.
Jochen Probst, Sonja Brechtel, Birgit Scheel, Ingmar Hoerr, Günther Jung

Genet Vaccines Ther· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas.
Jean-Philippe Carralot, Benjamin Weide, Oliver Schoor, Jochen Probst, Birgit Scheel, Ingmar Hoerr

Genet Vaccines Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor-dependent activation of several human blood cell types by protamine-condensed mRNA.
Birgit Scheel, Regina Teufel, Jochen Probst, Jean-Philippe Carralot, Jens Geginat, Ingmar Hoerr

Eur J Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis